Fahima Akther has completed her master’s in biomedical engineering from Chonnam National University, South Korea, and completed her Bachelor of Pharmacy from University of Development Alternative (UODA), Bangladesh. Her Ph.D. project focuses on the development of a site-specific microfluidics model for atherothrombosis and atherosclerotic plaque. The project aims to develop chips that mimic the biological processes of cardiovascular diseases, which allows testing new therapies freely on “subjects” without harming any living creatures and lessens the need for animal testing.
Fahima Akther has completed her master’s in biomedical engineering from Chonnam National University, South Korea, and completed her Bachelor of Pharmacy from University of Development Alternative (UODA), Bangladesh. Her Ph.D. project focuses on the development of a site-specific microfluidics model for atherothrombosis and atherosclerotic plaque. The project aims to develop chips that mimic the biological processes of cardiovascular diseases, which allows testing new therapies freely on “subjects” without harming any living creatures and lessens the need for animal testing.